Emilio Javier Frutos-Reoyo

Dr. Emilio Javier Frutos-Reoyo

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2025 in Clinical Orthopaedics and Related Research
Verified
Journal Article
Closed access
CSClarisa Simon-Perez
Clarisa Simon-Perez
Emilio Javier Frutos-ReoyoEmilio Javier Frutos-Reoyo
Emilio Javier Frutos-Reoyo
MMmiguel martin
miguel martin
IAIgnacio Aguado-Maestro
Ignacio Aguado-Maestro
LGLluis Guirao-Cano
Lluis Guirao-Cano
FMFrancisco Martínez
Francisco Martínez
Background: Trapeziometacarpal (TMC) osteoarthritis is the most prevalent osteoarthritis of the upper limb. It is one of the most disabling conditions. Currently, the most suitable surgical technique is debated. Trapeziectomy with ligamentoplasty continues to be the gold standard; however, results for function, esthetics, and quality of life have not been optimal. For this reason, surgeons have continued to refine and develop various surgical techniques, among which total arthroplasty is increasingly emerging as a major alternative, but it has not yet demonstrated superiority and its durability is still in doubt. Questions/purposes: At a minimum follow-up time of 5 years, do patients with total basilar thumb arthroplasty, compared with patients with trapeziectomy and ligament reconstruction, have (1) better pain as measured by a VAS scale, (2) lower disability as measured by the DASH, and (3) better tip pinch strength and functional range? Methods: This was a prospective study conducted in a specialized hand surgery unit within a tertiary-level referral hospital located in an urban area, with 54 patients diagnosed with TMC osteoarthritis administratively assigned to two different surgeons. Between February 2018 and June 2018, we treated 54 patients for TMC osteoarthritis. Of those, we considered as potentially eligible patients who met the following inclusion criteria: TMC osteoarthritis classified as Eaton-Littler Type III or IV, good bone quality, persistent pain lasting for > 6 months, and failure to respond to conservative treatment. The study was designed as a parallel group study in which patients treated by one surgeon were treated with total arthroplasty and patients treated by the other study surgeon were treated with trapeziectomy with ligamentoplasty. Patients were administratively assigned to their groups, and the surgeons were comparably experienced and performed similar surgical volumes. A total of 27 patients were treated with total arthroplasty, and 27 patients were treated with trapeziectomy with ligamentoplasty. One patient in the total arthroplasty group was lost to follow-up after the intervention for personal reasons unrelated to the study or the disorder. For this reason, that patient was excluded from the study. Finally, among the 26 patients who underwent arthroplasty at the end of the follow-up period, 96% (25) were women, and the mean ± SD age was 59 ± 8 years. Four percent (1) of patients were lost to follow-up before 5 years. Of the 27 patients who received ligament reconstruction and tendon interposition, 96% (26) were women with a mean ± SD age of 59 ± 7 years. A total of 0% (0) were lost to follow-up before 5 years. This left 96% (26) of patients in the total arthroplasty group and 100% (27) in the tendon interposition arthroplasty group, respectively. The mean ± SD follow-up time for all patients was 78 ± 4 months. The mean follow-up time for patients who received total arthroplasty was 78 ± 4 months, and it was 77 ± 3 months for those who received trapeziectomy with ligamentoplasty. The minimum follow-up period for inclusion was 5 years (60 months). Patients in the two treatment groups did not differ in terms of age, sex, dominant hand surgery, functional work requirement, concomitant disorder, radiographic characteristics, and Eaton-Littler stage, but a higher percentage of patients in the total arthroplasty group had carpal tunnel syndrome at the time of presentation (58% [15 of 26] versus 30% [8 of 27]; p = 0.04). Pain was assessed using a VAS ranging from 0 (pain free) to 10 (maximum pain), with a clinically significant change defined as 0.7 to 0.9. Functionality was evaluated using the DASH questionnaire, with a minimum clinically important difference (MCID) of 10.83. Secondary outcomes included mobility, measured through radial abduction and retropulsion of the thumb using a goniometer, and thumb opposition assessed by the Kapandji index, which scores opposition on a scale of 0 to 10. Grip strength was measured with a pinch gauge, averaging three measurements, with an MCID of 0.33 kg. Results: At 5 years, patients who had total arthroplasty had less pain compared to patients with trapeziectomy with ligament reconstruction (VAS 1.3 ± 0.7 versus 3.0 ± 0.9, mean difference 1.7 [95% confidence interval (CI) 1.3 to 2.1]; p < 0.001). Patients who had total arthroplasty had lower scores for upper extremity disability at 5 years (DASH 11 ± 9 versus 28 ± 12, mean difference -17 [95% CI -22 to -12]; p < 0.001). There was no clinically important difference between the groups in terms of tip pinch strength as measured in kg (3.7 ± 0.6 versus 3.2 ± 0.6, mean difference 0.4 [95% CI 0.1 to 0.8]; p = 0.01). Regarding mobility, we found differences between the total arthroplasty group and the trapeziectomy with ligamentoplasty group at 5 years of follow-up (Kapandji score 9.9 ± 0.4 versus 8.5 ± 0.6, mean difference 1.4 [95% CI 1.0 to 1.8]; p < 0.001). Conclusion: In light of these findings, surgeons should consider total arthroplasty as a first-line therapeutic option for patients with advanced TMC arthritis, especially those with significant pain and persistent functional limitations. While both treatments offer benefits, total arthroplasty provides superior pain relief and greater improvement in functional disability. Future studies should focus on the long-term durability of total arthroplasty compared to trapeziectomy with ligamentoplasty, with follow-up visits extending beyond 10 to 20 years to assess implant longevity and potential late complications. Level of Evidence Level II, therapeutic study.

Verified
Journal Article
Open access
PDF file
PLPaula Luque-Linero
Paula Luque-Linero
Emilio Javier Frutos-ReoyoEmilio Javier Frutos-Reoyo
Emilio Javier Frutos-Reoyo
LCLuis Castilla-Guerra
Luis Castilla-Guerra
MRMiguel Angel Rico
Miguel Angel Rico
PSPrado Salamanca-Bautista
Prado Salamanca-Bautista
FGFernando Garrachón-Vallo
Fernando Garrachón-Vallo
Introduction and Aim: Sarcopenia has emerged as a key prognostic factor in patients with chronic limb-threatening ischemia (CLTI), with potential implications for clinical decision-making. This study aimed to assess the association between sarcopenia and clinical outcomes, mortality, and amputation, using simple, accessible screening tools in a CLTI population. Methods: In this prospective, single-center study conducted between December 2023 and December 2024, 170 patients with CTLI were enrolled. Sarcopenia screening was performed using the SARC-F (strength, assistance in walking, rising from a chair, climbing stairs, falls) questionnaires, handgrip strength measurement, and calf circumference, adjusted for body mass index and sex. The primary outcome was 6-month all-cause mortality and/or major amputation. Results: Sarcopenia was identified in 77 patients (45.3%). Compared to non-sarcopenic individuals, sarcopenic patients were significantly older. They exhibited greater functional impairment, as well as poorer nutritional and muscle status. They also had significantly higher in-hospital mortality (16.9% vs. 3.2%, p = 0.002), 30-day mortality (24.7% vs. 4.3%, p = 0.001), and 6-month mortality (50.6% vs. 15.1%, p = 0.001). Sarcopenia was significantly associated with the primary outcome in univariate analysis (HR: 2.05; 95% CI: 1.31–3.20; p = 0.002) and remained an independent predictor after multivariate adjustment (HR: 1.95; 95% CI: 1.01–3.79; p = 0.048). Conclusions: Sarcopenia is a strong, independent predictor of poor outcome in patients with CLTI. Its detection through simple tools offers an easy and cost-effective strategy to improve risk stratification and guide early intervention through exercise-based therapy.

21 August 2023 in American Journal of Physical Medicine & Rehabilitation
Verified
Journal Article
Closed access
Emilio Javier Frutos-ReoyoEmilio Javier Frutos-Reoyo
Emilio Javier Frutos-Reoyo
RLRaúl López-Izquierdo
Raúl López-Izquierdo
PLPaula Luque-Linero
Paula Luque-Linero
ECEsther Cantalapiedra-Puentes
Esther Cantalapiedra-Puentes
MAMaría Jesús Antón-Andrés
María Jesús Antón-Andrés
ECErnesto Domingo Candau-Pérez
Ernesto Domingo Candau-Pérez
Purpose: The aim of the study is to evaluate the predictive factors for a poor prognosis in patients with facial paralysis evaluated in the rehabilitation department of a tertiary hospital. Methods: We have conducted a prospective cohort study. Patients who required elective botulinum toxin infiltration, surgical treatment, or follow-up appointments longer than 6 months due to incomplete recovery were considered to have a poor prognosis. Descriptive and analytical analyses of clinical and epidemiological variables were performed. The follow-up period was 6 mos. Results: A total of 47 adult patients were analyzed, 54.2% of whom were women. The mean age was 53.2 yrs (SD, 15.5 yrs). Twenty-five percent had an unfavorable prognosis. A statistically significant association with prognosis was observed for neurophysiological results and the scores of the House-Brackmann scale and the Sunnybrook Facial Grading System. Conclusions: Neurophysiological tests are especially useful when evaluating prognosis. Likewise, Sunnybrook Facial Grading System is a useful and accessible tool with prognostic value, especially within a month of initial diagnosis, when a score lower than 65 indicates a poor prognosis with high sensitivity and specificity. These tools can be especially useful to reduce the clinical and psychological impact and to provide patients with early therapeutic management.

Verified
Journal Article
Open access
PDF file
ICIgnacio García Cepeda
Ignacio García Cepeda
APAna Elena Sanz Peñas
Ana Elena Sanz Peñas
ISInés De Blas Sanz
Inés De Blas Sanz
CSClarisa Simon-Perez
Clarisa Simon-Perez
Emilio Javier Frutos-ReoyoEmilio Javier Frutos-Reoyo
Emilio Javier Frutos-Reoyo
IAIgnacio Aguado-Maestro
Ignacio Aguado-Maestro
Postoperative ulnar neuropathy is a common complication in patients undergoing surgery for distal humerus fractures, particularly when open reduction and internal fixation (ORIF) is performed. Objectives: This study aims to compare the rates of ulnar nerve neuropathy following classic in situ decompression versus ulnar nerve subcutaneous anterior transposition. Methods: A retrospective study was conducted, including 51 patients treated for distal humerus fractures with precontoured locking plates in our institution between 2009 and 2023, according to specific inclusion and exclusion criteria. Age, sex, ulnar neuropathy, range of motion (ROM), complications, surgical approach, and Mayo Elbow Performance Score (MEPS) were evaluated. Ulnar nerve function was graded according to modified McGowan classification. Results: Ulnar neuropathy was observed in 17 (33.3%) patients, with a higher risk in those who underwent anterior ulnar nerve transposition compared to in situ decompression (58% vs. 26%, p = 0.042). In the modified McGowan classification, 14 patients had grade 1 and 3 had grade 2 neuropathy. The overall complication rate was 49%, and the functional outcomes according to the MEPS scale showed a mean score of 81.6 (SD 17.29). The mean flexion–extension was 100.56°, and 94% of patients retained complete pronosupination. Conclusions: Our results demonstrate that routine intraoperative ulnar nerve transposition should not be performed for these fractures.

5 January 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
IAIgnacio Aguado-Maestro
Ignacio Aguado-Maestro
SVSergio Valle-López
Sergio Valle-López
CSClarisa Simon-Perez
Clarisa Simon-Perez
Emilio Javier Frutos-ReoyoEmilio Javier Frutos-Reoyo
Emilio Javier Frutos-Reoyo
ICIgnacio García Cepeda
Ignacio García Cepeda
CSCarlos Sanz-Posadas
Carlos Sanz-Posadas
Background: Hip fractures are prevalent among the elderly and impose a significant burden on healthcare systems due to the associated high morbidity and costs. The increasing use of intramedullary nails for hip fracture fixation has inadvertently introduced risks; these implants can alter bone elasticity and create stress concentrations, leading to peri-implant fractures. The aim of this study is to investigate the outcomes of peri-implant hip fractures, evaluate the potential causes of such fractures, determine the type of treatment provided, assess the outcomes of said treatments, and establish possible improvement strategies. Methods: We conducted a retrospective observational study on 33 patients with peri-implant hip fractures (PIFs) who underwent surgical management at Río Hortega University Hospital from 2010 to 2022. The collected data included demographics, initial fracture characteristics, the peri-implant fracture classification, implant details, surgical outcomes, functional scores, and complications. Functional capacity was evaluated using the Parker Mobility Score (PMS). Results: The cohort (91% female, mean age 87.6 years) included 34 peri-implant fractures. The mean time from the initial fracture to the PIF was 47.2 months (nine patients developed PIFs within 2 months). Most fractures (76%) were managed with implant removal and the insertion of a long intramedullary nail, with cement augmentation in 31% of cases. The mean surgical time was 102 min, and the average hospital stay was 9.6 days. Postoperative complications occurred in 27%, with a perioperative mortality rate of 9%. Functional capacity showed a significant decline, with an average PMS loss of 4.16 points. Mortality at one year post-PIF was 36%, rising to 83% at five years. Radiographic consolidation was observed in 72% of cases at an average of 6.04 months, though 24% of patients died before consolidation. Statistically significant correlations were found for PMS pre-index fracture (PMS1: r = 0.354, p < 0.05), pre-PIF (PMS2: r = 0.647, p < 0.001), and post-PIF (PMS3: r = 0.604, p < 0.001). Conclusions: Peri-implant hip fractures present complex challenges due to their surgical difficulty and impact on patient mobility and survival. Successful management requires individualized treatment based on fracture type, implant positioning, and patient factors. These findings underscore the need for preventive measures, particularly in implant choice and techniques like overlapping and interlocking constructs, to minimize the secondary fracture risk.

17 February 2025 in Revista de Psicología de la Salud
Verified
Journal Article
Open access
PDF file
Emilio Javier Frutos-ReoyoEmilio Javier Frutos-Reoyo
Emilio Javier Frutos-Reoyo
LLLaura López-Maté
Laura López-Maté
MGMarcos Gándara-Alonso
Marcos Gándara-Alonso
LGLaura González-Fraile
Laura González-Fraile
SSSara Sastre-Parro
Sara Sastre-Parro
ECErnesto Domingo Candau-Pérez
Ernesto Domingo Candau-Pérez
Introduction: Colorectal cancer is one of the most common tumours. The impact on the functionality and quality of life of these patients is enormous. However, the emotional impact has not been analysed as much. Prehabilitation can help to address this major impact. Objective: To quantify the impact on the functionality and quality of life of patients diagnosed with colorectal cancer. Methods: Observational cross-sectional study of all patients diagnosed with colorectal cancer and undergoing surgery in a tertiary hospital over a calendar year. Results: A total of 127 patients were included, 68.5% were male. The most frequent tumour staging according to the AJCC classification was IIIB. Regarding quality of life as measured by the SF-12, a score of 48.18 was obtained for the SF-12 MCS and 51.79 for the SF-12 PCS. Regarding functionality, a mean score of 464.54 was observed for the 6MWT, 9.20 for the TUG and 52.27 for the PIM. Statistically significant differences were found between 6MWT and staging (p<0.05). Conclusion: Patients affected by colorectal cancer experience a great impact on functionality and quality of life that require a multidisciplinary approach that includes prehabilitation to mitigate these effects, reducing the costs and mortality of this pathology.